» Articles » PMID: 9436726

Chromosome 14 Familial Alzheimer's Disease: the Clinical and Neuropathological Characteristics of a Family with a Leucine-->serine (L250S) Substitution at Codon 250 of the Presenilin 1 Gene

Overview
Date 1998 Jan 22
PMID 9436726
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Seven affected members are described from a kindred with autosomal dominant familial Alzheimer's disease associated with a novel mutation in the presenilin 1 (PS1) gene on chromosome 14 that results in a leucine to serine substitution at codon 250 (L250S).

Method: Clinical information on the pedigree was collected directly from family members including affected members and their carers and also from hospital records.

Results: Detailed clinical information was available on five members. All had an early age at onset with a median age of 52 (95% confidence interval (95% CI) 49.4-54.9). Age at onset varied between 49 and 56 years, with duration of illness varying between six years and 15 years. Myoclonus, depression, and psychosis were features of this pedigree; seizures were not reported.

Conclusions: PS1 L250S familial Alzheimer's disease is an early onset form of Alzheimer's disease with clinical features similar to other reported familial Alzheimer's disease pedigrees, except that seizures were absent.

Citing Articles

Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses.

Justice N, Huang L, Tian J, Cole A, Pruski M, Hunt Jr A J Neurosci. 2015; 35(6):2612-23.

PMID: 25673853 PMC: 4323535. DOI: 10.1523/JNEUROSCI.3333-14.2015.


Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis.

Couthouis J, Raphael A, Daneshjou R, Gitler A PLoS Genet. 2014; 10(10):e1004704.

PMID: 25299611 PMC: 4191946. DOI: 10.1371/journal.pgen.1004704.


The usefulness of biological and neuroimaging markers for the diagnosis of early-onset Alzheimer's disease.

Padovani A, Gilberti N, Borroni B Int J Alzheimers Dis. 2011; 2011:296374.

PMID: 21559247 PMC: 3087487. DOI: 10.4061/2011/296374.


Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD).

Liperoti R, Pedone C, Corsonello A Curr Neuropharmacol. 2009; 6(2):117-24.

PMID: 19305792 PMC: 2647149. DOI: 10.2174/157015908784533860.


Depression and psychiatric symptoms preceding onset of dementia in a family with early-onset Alzheimer disease with a novel PSEN1 mutation.

Kasuga K, Ohno T, Ishihara T, Miyashita A, Kuwano R, Onodera O J Neurol. 2009; 256(8):1351-3.

PMID: 19280102 DOI: 10.1007/s00415-009-5096-4.


References
1.
Cairns N, Chadwick A, Lantos P, Levy R, Rossor M . Beta A4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the beta A4 amyloid precursor protein gene and sporadic Alzheimer's disease. Neurosci Lett. 1993; 149(2):137-40. DOI: 10.1016/0304-3940(93)90755-a. View

2.
Schellenberg G, Bird T, Wijsman E, Orr H, Anderson L, Nemens E . Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 1992; 258(5082):668-71. DOI: 10.1126/science.1411576. View

3.
Mullan M, Houlden H, Windelspecht M, Fidani L, Lombardi C, Diaz P . A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet. 1992; 2(4):340-2. DOI: 10.1038/ng1292-340. View

4.
Rossor M . Molecular pathology of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1993; 56(6):583-6. PMC: 489603. DOI: 10.1136/jnnp.56.6.583. View

5.
Haltia M, Viitanen M, Sulkava R, Poyhonen M, Goldfarb L, Brown P . Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol. 1994; 36(3):362-7. DOI: 10.1002/ana.410360307. View